Urolithin A dosage and evidence

Overview

Mechanism of action

Induces mitophagy, clearing damaged mitochondria and improving the quality of the cellular energy supply, especially in muscle.

Human evidence

Three human trials, all short, all on muscle and mitochondria rather than lifespan. Safety is fine. The headline function measures keep missing.

• First-in-human 2019: sedentary older adults, safe, with blood and muscle signatures of mitochondrial change. No strength or stamina outcome.
• Older-adult RCT 2022: 4 months. Muscle endurance and plasma markers improved. Six-minute walk and peak ATP did not differ from placebo.
• Middle-aged RCT 2022: about 12% gain in muscle strength, with better VO2 peak and six-minute walk. The primary peak-power endpoint was not met.

What this does not tell you: No trial has asked whether urolithin A changes how long a person lives, or how they die. Missing the measure a trial names first, then hitting others, is a weaker form of evidence than hitting the one it named.

The evidence, charted

Key studies & citations

• Human2019
  The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans

  The first human test asked whether it was safe and whether the body showed any sign of it working. Sedentary older adults took it, tolerated it, and their blood and muscle showed chemical patterns pointing to healthier mitochondria, the parts of a cell that make energy. Nothing about strength, stamina or how anybody felt was measured here.

  First-in-human trial in sedentary elderly adults: safe, with plasma and muscle signatures of improved mitochondrial health.

  PMID 32694802 Nature Metabolism
• Human2022
  Effect of urolithin A supplementation on muscle endurance and mitochondrial health in older adults: a randomized clinical trial

  Four months of it improved muscle endurance and blood chemistry, and left the headline measures untouched. Older adults took the supplement or a dummy. How far they could walk in six minutes did not differ, and neither did the peak energy their muscles could produce. What improved was how long a muscle could keep going, plus several markers. A genuine result, and a narrow one.

  4 months of urolithin A improved muscle endurance and plasma biomarkers, though 6-minute walk and peak ATP did not differ from placebo.

  PMID 35050355 JAMA Network Open
• Human2022
  Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults

  Strength improved, and the trial still missed the thing it was built to show. Muscle strength in middle-aged adults rose about 12 percent, and fitness and walking distance improved as well. But peak power, the one measure chosen before the trial began, did not. When a study misses the measure it named first and hits others instead, those others carry less weight.

  About 12% gain in muscle strength and improved VO2 peak and 6-minute walk, though the primary peak-power endpoint was not met.

  PMID 35584623 Cell Reports Medicine

What users report

Self-reported experiences, not evidence. Nothing below was measured under controlled conditions, and reports like these cannot separate a real effect from placebo, from the training or diet change that accompanied it, or from what the product actually contained. They are here because knowing what people describe, including what goes wrong, is worth reading alongside the studies.

• Discussion volume is low and the accounts diverge rather than converge, so there is no pattern here to report, only a spread.
• The most detailed negative account describes four months of daily use of the branded powder with no change in strength, endurance or power output, and frames the spend of several hundred dollars as wasted. Another describes overwhelming fatigue while taking it. A third describes a clean lift in energy.
• Cost is the recurring objection and is what people cite when they stop.
• Where it appears on health forums it is usually as a posted article or conference summary rather than as anyone's experience, and the comment threads under those posts contain almost no personal use at all, which limits what can honestly be said about it.

Sources: LongeCity supplement threads reached through site-restricted search extracts because that board timed out on direct fetch from this environment, together with ExcelMale threads read directly which turned out to carry article content rather than member experience, September 2026. Nothing above is attributed to any specific post and no post is reproduced.